1. Market Research
  2. > Biotechnology
  3. > Genomics Market Trends
  4. > Novel Autism Diagnostics

Novel Autism Diagnostics

  • February 2015
  • -
  • Kalorama Information
  • -
  • 130 pages

Autism spectrum disorder (ASD) includes many syndromes that can range in severity from the social awkwardness and narrow interests to severe communication and intellectual disabilities. There is a growing demand for cost efficient tests that can help physicians diagnose and monitor chronic diseases such autism. There is therefore a market opportunity for highly sensitive, specific and cost effective screening tests for early diagnosis. Novel Autism Diagnostics examines selected autism test innovations that have emerged.

Novel Autism Diagnostics outlines many of the current approaches to autism testing, including molecular testing, pre-disposition screening, targeted sequencing-based testing, next-generation sequencing with modeling, genetic risk assessment / testing, cloud platform approaches, microarrays, end-to-end sequencing, gene variants, and blood-based genetic testing. The report looks at the companies behind these testing approaches as well.

The competitors discussed within the company profiles include Asuragen, Google Genomics, Illumina, and LabCorp.

The information presented in this report is the result of data gathered from government reports, company product literature and other corporate brochures and documents, as well as information found in the scientific and trade press.

Table Of Contents

Novel Autism Diagnostics
ONE: EXECUTIVE SUMMARY
Overview of ASD
Leading Competitors
Methodology
TWO: NOVEL AUTISM DIAGNOSTICS
Overview of Autism
Screening and Diagnosis
Developmental Screening
Comprehensive Diagnostic Evaluation
Emerging Diagnostics
Potential Market
Research
THREE: COMPANY PROFILES
Ambry Genetics Corp.
ARUP Laboratories
Asuragen Inc.
Controls
Sample Collection
Sequencing
Athena Diagnostics, Inc. (A Quest Diagnostics Business)
Claritas Genomics, Inc.
CombiMatrix Corp.
Oncology
Courtagen Life Sciences, Inc.
Emory Genetics Laboratory
GenePeeks, Inc.
Genoma SA (a Subsidiary of the Esperite group)
Google Genomics
Greenwood Genetic Center
Illumina
Sequencing
Sequencing Kits
Sample Prep
IVD Business
Oncology
HLA Typing
IT
Forensics
CLIA Lab Service
Nanopore Sequencing
Sample to Insight
Making a Market
IP Situation
IntegraGen
LabCorp, Laboratory Corporation of America
Infectious Diseases
Prenatal
Sequencing
Oncology
BRCA Saga
Information Technology
Forensic
Collaborations
Life Technologies Corporation
Instrumentation and Applications
Liquid Biopsy
Sequencing
Life Technologies an IVD Company
Partnerships Worldwide
Life and Quidel Develop Diagnostics on the 7500 Fast Dx
Sepsis
HIV
Emerging Pathogens
Bacterial Typing
Personalized Medicine
Forensic
Lineagen, Inc.
MEDomics, LLC
Population Diagnostics
RainDance Technologies, Inc.
SynapDx Corporation
Transgenomic, Inc.


LIST OF EXHIBITS
ONE: EXECUTIVE SUMMARY
Table 1-1: Identified Prevalence of Autism Spectrum Disorder (ADDM Network, 2000-2010)
TWO: NOVEL AUTISM DIAGNOSTICS
Table 2-1: Selected Autism Test Innovations
Table 2-2: Global Clinical Laboratory Services Market for Neonatal and Pediatric Testing, 2015 and 2020
Table 2-3: Geographical Distribution of Laboratories Performing Genetic Testing Services

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
The Chinese Market for DNA Sequencing

The Chinese Market for DNA Sequencing

  • $ 6650
  • Industry report
  • September 2016
  • by BCC Research

Use this report to: - Learn about recent advances and trends in the Chinese sequencing industry and market. - Analyze the Chinese sequencing market by workflow, including sample preparation products, ...

Next Generation Sequencing (NGS) Global market - Forecast to 2022

Next Generation Sequencing (NGS) Global market - Forecast to 2022

  • $ 4950
  • Industry report
  • November 2016
  • by IQ4I Research & Consultancy Pvt. Ltd

A decade has gone, since the first human genome has been sequenced and sequencing technology has come a long way from the time of introduction as Next generation Sequencing (NGS) has revolutionized the ...

Global Precision Medicine Market

Global Precision Medicine Market

  • $ 4250
  • Industry report
  • December 2016
  • by Mordor Intelligence LLP

The global precision medicine market is expected to reach close to USD 40 billion by the end of 2016, gradually growing at an estimated CAGR of 10.3% by 2021. Precision medicine is an emerging approach ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.